ctg-pharma.com | CTG-Pharma – CTG’s revolutionary SAFE and EFFICIENT CAR T therapy for patients with solid

Robots.txt Information

Robot	Path	Permission
GoogleBot	/	✔
BingBot	/	✔
BaiduSpider	/	✔
YandexBot	/	✔
User-agent: * Disallow: /wp-admin/ Allow: /wp-admin/admin-ajax.php

Meta Tags

Title	CTG-Pharma – CTG’s revolutionary SAFE and EFFICIENT CAR T therapy for patients with solid
Description	CTG’s revolutionary SAFE and EFFICIENT CAR T therapy for patients with solid tumors Toggle menu Home About us Our Story Our Team Our Partners Science Back
Keywords	N/A

Server Information

WebSite	ctg-pharma.com
Host IP	185.119.173.68
Location	-

Related Websites

                        Site
                        Rank
                    

More to Explore

ctg-pharma.com Valuation

US$526,915

Last updated: 2022-07-20 19:33:03

ctg-pharma.com has Semrush global rank of 20,087,326. ctg-pharma.com has an estimated worth of US$ 526,915, based on its estimated Ads revenue. ctg-pharma.com receives approximately 60,798 unique visitors each day. Its web server is located in -, with IP address 185.119.173.68. According to SiteAdvisor, ctg-pharma.com is safe to visit.

Traffic & Worth Estimates

Purchase/Sale Value	US$526,915
Daily Ads Revenue	US$487
Monthly Ads Revenue	US$14,592
Yearly Ads Revenue	US$175,098
Daily Unique Visitors	4,054
Note: All traffic and earnings values are estimates.

DNS Records

Host	Type	TTL	Data
ctg-pharma.com.	A	86400	IP: 185.119.173.68
ctg-pharma.com.	NS	86400	NS Record: ns1.tsohost.co.uk.
ctg-pharma.com.	NS	86400	NS Record: ns2.tsohost.co.uk.
ctg-pharma.com.	MX	3600	MX Record: 5 alt1.aspmx.l.google.com.
ctg-pharma.com.	MX	3600	MX Record: 1 aspmx.l.google.com.
ctg-pharma.com.	MX	3600	MX Record: 5 alt2.aspmx.l.google.com.
ctg-pharma.com.	MX	3600	MX Record: 10 aspmx3.googlemail.com.
ctg-pharma.com.	MX	3600	MX Record: 10 aspmx2.googlemail.com.
ctg-pharma.com.	TXT	600	TXT Record: google-site-verification=6I4gaiBGvACSMtVkdVCW0-YtKxCLR7FBh3rNuu7kk4s
ctg-pharma.com.	TXT	3600	TXT Record: v=spf1 include:_spf.google.com ~all

HtmlToTextCheckTime:2022-07-20 19:33:03

CTG’s revolutionary SAFE and EFFICIENT CAR T therapy for patients with solid tumors Toggle menu Home About us Our Story Our Team Our Partners Science Background The Challenge The Solution Our Pipeline Partnerships Contact Us CTG develops a revolutionary solution: Re-designed CAR T for better & safer therapy Home IN ORDER TO RECOGNIZE AND FIGHT TUMOR CELLS. Chimeric Antigen Receptor T cells (CAR T), developed by Prof. Zelig Eshhar (Weizmann Institute of Science), is a promising therapy that comprises the genetic engineering of T cells in order to make them express artificial receptors endowing them with the ability to recognize and attack tumor cells. CAR T treatment is successfully applied in certain types of hematological malignancies like Acute Lymphoblastic Leukemia (ALL) and Diffuse Large B Cell Lymphoma (DLBCL). Despite that, no encouraging results have been obtained in solid tumors, mostly due to poor efficiency and high toxicity issues. KNOW MORE ABOUT CTG PHARMA THE NEED One

HTTP Headers

HTTP/1.1 200 OK
Date: Wed, 03 Nov 2021 22:24:29 GMT
Server: Apache
Link: ; rel="https://api.w.org/", ; rel=shortlink
Content-Type: text/html; charset=UTF-8
X-Cache: MISS from lin-10-170-0-114.gridhost.co.uk
X-Cache-Lookup: HIT from lin-10-170-0-114.gridhost.co.uk:3128
Connection: close

ctg-pharma.com Whois Information

Domain Name: CTG-PHARMA.COM
Registry Domain ID: 2061019271_DOMAIN_COM-VRSN
Registrar WHOIS Server: whois.godaddy.com
Registrar URL: http://www.godaddy.com
Updated Date: 2021-09-23T10:47:54Z
Creation Date: 2016-09-22T08:35:29Z
Registry Expiry Date: 2026-09-22T08:35:29Z
Registrar: GoDaddy.com, LLC
Registrar IANA ID: 146
Registrar Abuse Contact Email: abuse@godaddy.com
Registrar Abuse Contact Phone: 480-624-2505
Domain Status: clientDeleteProhibited https://icann.org/epp#clientDeleteProhibited
Domain Status: clientRenewProhibited https://icann.org/epp#clientRenewProhibited
Domain Status: clientTransferProhibited https://icann.org/epp#clientTransferProhibited
Domain Status: clientUpdateProhibited https://icann.org/epp#clientUpdateProhibited
Name Server: NS1.TSOHOST.CO.UK
Name Server: NS2.TSOHOST.CO.UK
Name Server: NS3.TSOHOST.CO.UK
DNSSEC: unsigned
>>> Last update of whois database: 2021-10-14T06:08:23Z <<<

ctg-pharma.com valuation and analysis